Chennai February 19, 2014: Mumbai-based Lupin Ltd has appointed Maurice Chagnaud as its President, Europe, and the Head of Strategy for its inhaler drugs business in developed markets.
The role will expect Chagnaud to devise strategy for its generic and specialty drugs verticals in the CIS region.
His previous stint was with Israeli drug-maker Teva, where he oversaw €1 billion in sales in central and eastern European operations as Senior Vice- President. Shamsher Gorawara, Head-Corporate Communications, said the post has been created to help the company consolidate its operations in Europe after it acquired a German drug-maker Hormosan Pharma in 2008.-
New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…
Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Winter weather brings a host…
By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…